Skip to content
4 things to know during C. diff Awareness Month
When Peggy Lillis was put on an antibiotic to treat an abscess after a root canal, her family had no idea of what was […]
4 things to know during C. diff Awareness Month Read More »
MAPRx is helping patients navigate open enrollment
It is open enrollment season for Medicare Part D, and the patient-led advocacy coalition MAPRx is helping patients get the coverage they need. Open
MAPRx is helping patients navigate open enrollment Read More »
BIO makes recommendation for new FDA Rare Disease Innovation Hub
The U.S. Food and Drug Administration (FDA) announced the creation of its Rare Disease Innovation Hub in July 2024. With the goal of engaging
BIO makes recommendation for new FDA Rare Disease Innovation Hub Read More »
PHAS 2024: Patient advocates unite to share stories and address barriers to treatment
Patient advocates from across the country gathered in Washington, D.C., on October 23-24 for the BIO Patient and Health Advocacy Summit (PHAS). This event
PHAS 2024: Patient advocates unite to share stories and address barriers to treatment Read More »
BIF 2024: AI experts discuss use cases, benefits, ROI
“All of us have been paying attention and seeing the ‘AI high’ for the last several years,” said Ruchita Sinha, MBA, General Partner at
BIF 2024: AI experts discuss use cases, benefits, ROI Read More »
BIF 2024: ‘The IRA really disrupted how we think’
The Inflation Reduction Act (IRA) has been top of mind for many in the biotech industry. The first round of price negotiations and the
BIF 2024: ‘The IRA really disrupted how we think’ Read More »
BIF 2024: What’s happening with neurodegenerative disease targets and pipelines?
There is a great degree of renewed optimism for drug development in the neurodegenerative disease space. “Some of that optimism has obviously come from
BIF 2024: What’s happening with neurodegenerative disease targets and pipelines? Read More »
AMR continues to pose a global threat
September was a big month for those following antimicrobial resistance (AMR). A new study highlighted the growing public health burden of AMR, and the
AMR continues to pose a global threat Read More »
BIO speaks on Capitol Hill about mpox preparedness
Mpox has proven to be a major public threat since its resurgence globally during the COVID years. As Bio.News reported, “On Aug. 14, the
BIO speaks on Capitol Hill about mpox preparedness Read More »
Sepsis Awareness Month: 3 things you need to know about sepsis
September is Sepsis Awareness Month, and the Biotechnology Innovation Organization (BIO) is partnering with Sepsis Alliance to spread the word about sepsis and provide
Sepsis Awareness Month: 3 things you need to know about sepsis Read More »